However, Huang et al. (2012) [71] demonstrated that, in considering pamidronate treatment in postmenopausal patients with osteoporosis receiving hemodialysis, it might be safer to add calcitriol to prevent increased PTH secretion [71]. This evidence concerns the gene PTH and osteoporosis.